 Personalized medicine is already being used in practice in the oncology field.A lot of research is being done to develop a biologic that can be delivered orally to address the many drawbacks associated with systemic administration.The general consensus in the field is that oral delivery of biologics directly to the diseased tissue could greatly reduce side effects, the development of anti-drug antibodies, and the cost of treatment.